GO:0060090 molecular adaptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060090 molecular adaptor activity describes the binding activity of a molecule that brings together two or more molecules through selective, non-covalent, often stoichiometric interactions, permitting coordinated function.
• Adaptor proteins lack intrinsic catalytic activity but are essential for assembling signaling complexes, such as the dynein-dynactin complex by LIS1 and the STING-TBK1-IRF3 axis.
• Dysregulated adaptor activity contributes to fibrosis through YAP/TAZ mechanosignaling [3,5] and to inflammatory diseases via NF-κB and NLRP3 regulation [4,6].
• Key adaptor genes include LIS1, STING1, MAVS, NEK7, YAP1, and WWTR1 (TAZ), each mediating distinct cellular processes [2,3,5,6,7,8].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise interrogation of adaptor protein function in disease contexts.
• Understanding molecular adaptor activity is critical for developing targeted therapies in cancer, fibrosis, neurodegeneration, and innate immune disorders.
Description
Molecular adaptor activity (GO:0060090) is a fundamental molecular function that enables the assembly of multiprotein complexes without direct catalytic involvement. This activity is defined as the binding of a molecule that brings together two or more molecules through selective, non-covalent, often stoichiometric interactions, allowing those molecules to function in a coordinated manner. Adaptor proteins serve as scaffolds or bridges, facilitating signal transduction, cytoskeletal dynamics, and immune responses. For researchers, GO:0060090 represents a key node in understanding how cells organize complex biological processes, from dynein-dynactin assembly mediated by LIS1 to antiviral signaling through MAVS prion-like aggregates. The importance of molecular adaptor activity extends to human disease, as dysregulation of adaptor proteins is implicated in fibrosis [3,5], inflammation [4,6], and cancer. This article provides a comprehensive overview of the mechanisms, key genes, research models, and methodologies for studying molecular adaptor activity, with a focus on CRISPR-based approaches.
molecular adaptor activity At A Glance
| GO ID | GO:0060090 |
|---|---|
| GO term | molecular adaptor activity |
| Ontology | molecular_function |
| Synonym | binding, bridging |
| Definition | The binding activity of a molecule that brings together two or more molecules through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way. |
| Major function | Assembly of multiprotein complexes and coordination of signaling pathways |
| Examples | LIS1 in dynein-dynactin assembly; STING in IRF3 phosphorylation; MAVS in antiviral signaling |
| Related diseases | Fibrosis, inflammatory disorders, cancer, neurodegeneration |
What Is GO:0060090?
According to the Gene Ontology, molecular adaptor activity (GO:0060090) is the binding activity of a molecule that brings together two or more molecules through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way. In simpler terms, it is the ability of a protein to act as a bridge or scaffold, physically linking other proteins or molecules so they can work together efficiently. This activity is distinct from enzymatic catalysis; adaptor proteins typically lack catalytic domains but contain modular interaction domains (e.g., SH2, SH3, PDZ) that mediate specific protein-protein interactions. The synonym 'binding, bridging' captures this role.
Why Is molecular adaptor activity Important in Cell Biology?
Molecular adaptor activity is crucial because it underlies the spatial and temporal organization of cellular signaling. Without adaptor proteins, many key pathways—such as innate immune sensing, mechanotransduction, and cytoskeletal transport—would fail to assemble efficiently. For instance, LIS1 acts as a molecular adaptor to facilitate dynein-dynactin complex assembly, which is essential for neuronal migration and intracellular transport. Similarly, STING serves as an adaptor that bridges cytosolic DNA sensing to TBK1-mediated IRF3 phosphorylation, and MAVS forms prion-like aggregates to propagate antiviral signaling. Dysregulation of these adaptor functions is linked to fibrosis [3,5], autoinflammatory diseases [4,6], and cancer. Therefore, studying GO:0060090 provides insights into both basic cell biology and therapeutic targeting.
• Enables assembly of signaling complexes such as the dynein-dynactin complex by LIS1.
• Facilitates innate immune responses through STING-TBK1-IRF3 and MAVS signaling [7,8].
• Regulates inflammasome activation via NEK7 and NF-κB-mediated mitochondrial clearance [4,6].
• Drives mechanosignaling and fibrosis through YAP/TAZ adaptor functions [3,5].
• Contributes to cancer progression when adaptor proteins are mutated or overexpressed.
• Provides targets for therapeutic intervention in inflammatory and fibrotic diseases.
• Essential for neuronal development and function via LIS1 and related adaptors.
• Offers opportunities for CRISPR-based functional genomics and drug discovery.
Molecular Adaptor Activity: Mechanisms and Components
What Happens During molecular adaptor activity?
In simple terms: An adaptor protein acts like a molecular bridge, grabbing two or more other proteins and holding them together so they can work as a team.
During molecular adaptor activity, a protein with multiple interaction domains binds to distinct partner molecules simultaneously or sequentially. This binding is selective and non-covalent, often occurring in a stoichiometric manner. For example, LIS1 binds to both dynein and dynactin, promoting their assembly into a functional motor complex. Similarly, STING binds to TBK1 and IRF3, facilitating IRF3 phosphorylation. The adaptor itself does not catalyze a reaction but ensures that the right molecules are in the right place at the right time.
Structure and Composition of molecular adaptor activity
In simple terms: Adaptor proteins are built from modular domains that recognize specific partners, like Lego bricks that connect different pieces.
Adaptor proteins typically contain modular protein-protein interaction domains such as SH2, SH3, PDZ, or death domains. For instance, STING contains a transmembrane domain and a cytoplasmic domain that recruits TBK1 and IRF3. MAVS uses its CARD domain to interact with RIG-I and its transmembrane domain to localize to mitochondria, forming prion-like aggregates. LIS1 contains a WD40 domain that mediates interactions with dynein and dynactin. These structural features enable selective and coordinated assembly of signaling complexes.
Molecular Mechanism of molecular adaptor activity
In simple terms: The adaptor works by holding partners close together, often inducing conformational changes or stabilizing transient interactions.
At the molecular level, adaptor activity involves binding-induced conformational changes or proximity effects. For example, LIS1 binding to dynein-dynactin induces a conformational shift that activates the motor for processive movement. STING oligomerization upon ligand binding creates a platform for TBK1 autophosphorylation and subsequent IRF3 phosphorylation. MAVS forms functional prion-like aggregates that serve as signaling platforms for antiviral innate immunity. These mechanisms highlight how adaptors can convert binding events into functional outputs.
Regulation of molecular adaptor activity
In simple terms: Adaptor activity is turned on or off by modifications, binding partners, or cellular signals.
Adaptor activity is regulated by post-translational modifications, such as phosphorylation, ubiquitination, or SUMOylation, which can alter binding affinities or localization. For instance, NF-κB restricts inflammasome activation by eliminating damaged mitochondria, a process that involves adaptor proteins. NEK7 is essential for NLRP3 activation downstream of potassium efflux, acting as an adaptor that links potassium signals to inflammasome assembly. YAP/TAZ adaptor functions are regulated by mechanical cues and TGF-β signaling, influencing fibrosis [3,5]. Thus, adaptor activity is dynamically controlled in response to cellular context.
Key Genes Involved in GO:0060090 molecular adaptor activity
The following genes encode proteins with molecular adaptor activity, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LIS1 | Assembles dynein-dynactin complex | Neuronal migration, intracellular transport |
| STING1 | Bridges cytosolic DNA sensing to TBK1-IRF3 | Innate immunity, autoinflammatory diseases |
| MAVS | Forms prion-like aggregates for antiviral signaling | Antiviral innate immunity |
| NEK7 | Mediates NLRP3 inflammasome activation | Inflammation, potassium efflux signaling |
| YAP1 | Mechanosignaling adaptor in fibrosis | Fibroblast activation, tissue remodeling [3,5] |
| WWTR1 (TAZ) | Mechanosignaling adaptor in fibrosis | Fibroblast activation, tissue remodeling [3,5] |
| NF-κB | Regulates inflammasome via mitochondrial clearance | Inflammation, mitochondrial homeostasis |
| TBK1 | Kinase recruited by STING | IRF3 phosphorylation, antiviral response |
| IRF3 | Transcription factor phosphorylated by TBK1 | Interferon response |
| Dynein | Motor protein interacting with LIS1 | Intracellular transport |
| Dynactin | Co-factor for dynein, binds LIS1 | Intracellular transport |
| NLRP3 | Inflammasome sensor, activated by NEK7 | Inflammation |
| TGF-β | Signaling ligand regulating YAP/TAZ | Fibrosis |
| SMAD | Transcription factors in TGF-β signaling | Fibrosis |
| RIG-I | Cytosolic RNA sensor upstream of MAVS | Antiviral immunity |
| Myokines | Muscle-derived factors in crosstalk | Muscle-bone-fat communication |
| Osteokines | Bone-derived factors in crosstalk | Muscle-bone-fat communication |
How Is molecular adaptor activity Regulated?
Molecular adaptor activity is regulated at multiple levels. Post-translational modifications such as phosphorylation can modulate binding affinities; for example, TBK1 phosphorylation of STING is critical for IRF3 activation. Ubiquitination and degradation of adaptor proteins can terminate signaling, as seen with NF-κB-mediated clearance of damaged mitochondria. Mechanical cues regulate YAP/TAZ adaptor function, influencing fibrosis [3,5]. Additionally, potassium efflux triggers NEK7-dependent NLRP3 activation. These regulatory mechanisms ensure that adaptor activity is tightly controlled in space and time.
molecular adaptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STING1 | Autoinflammatory diseases, interferonopathies | Knock-in of patient mutations in cell lines |
| NEK7 | Inflammatory disorders, NLRP3-associated diseases | Knockout in macrophages, inflammasome assays |
| YAP1/WWTR1 | Fibrosis, cancer | Overexpression and knockout in fibroblasts |
| LIS1 | Lissencephaly, neuronal migration disorders | Knockout in neural stem cells, migration assays |
| MAVS | Antiviral immunity, autoimmune diseases | Knockout in immune cells, viral infection models |
Molecular Adaptor Activity in Fibrosis
Fibrosis is characterized by excessive extracellular matrix deposition and fibroblast activation. YAP and TAZ, which exhibit molecular adaptor activity, are mechanosignaling effectors that drive fibroblast activation and fibrosis. TGF-β/SMAD signaling crosstalks with YAP/TAZ to promote skeletal muscle fibrosis. Targeting adaptor proteins like YAP/TAZ may offer therapeutic strategies for fibrotic diseases.
Molecular Adaptor Activity in Inflammatory and Autoimmune Diseases
Adaptor proteins are central to innate immune signaling. STING acts as an adaptor to bridge cytosolic DNA sensing to TBK1-IRF3 phosphorylation, and mutations in STING cause autoinflammatory diseases. MAVS forms prion-like aggregates to propagate antiviral responses, and dysregulation can lead to autoimmune conditions. NEK7 is essential for NLRP3 inflammasome activation, linking potassium efflux to IL-1β production. NF-κB restricts inflammasome activation by eliminating damaged mitochondria, highlighting crosstalk between adaptor-mediated pathways.
Molecular Adaptor Activity in Cancer and Neurodegeneration
Dysregulated adaptor activity contributes to cancer progression and neurodegeneration. LIS1, a key adaptor for dynein-dynactin assembly, is critical for neuronal migration; mutations in LIS1 cause lissencephaly. In cancer, YAP/TAZ adaptor functions promote tumor growth and metastasis [3,5]. Understanding these roles can inform targeted therapies.
From molecular adaptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of adaptor function affect signaling? | CRISPR knockout cell lines |
| How do point mutations in adaptor domains alter binding? | CRISPR point mutation knock-in |
| Can we visualize adaptor localization? | Tagged knock-in (e.g., GFP) via CRISPR |
| Does overexpression of adaptor drive disease phenotypes? | CRISPR overexpression (e.g., CRISPRa) |
| Which genes interact with a specific adaptor? | CRISPR library screening (e.g., genome-wide KO) |
| What are the transcriptomic changes upon adaptor loss? | RNA-seq after CRISPR knockout |
How to Study the molecular adaptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and pathway components | Identify regulators of adaptor signaling |
| AP-MS | Protein-protein interactions | Map adaptor interactome |
| BioID proximity labeling | Transient and weak interactions | Capture dynamic adaptor complexes |
| Live-cell imaging | Localization and dynamics | Visualize adaptor recruitment |
| RNA-seq | Transcriptional changes | Assess downstream effects of adaptor loss |
| Inflammasome assays | IL-1β production | Measure NEK7/NLRP3 adaptor function |
| Interferon reporter assays | IRF3 activation | Measure STING/MAVS adaptor activity |
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate molecular adaptor activity. For example, screens for regulators of STING or MAVS signaling have uncovered novel adaptors [7,8]. These screens are powerful for discovering synthetic lethal interactions or pathway components.
Proteomic Approaches
Affinity purification coupled with mass spectrometry (AP-MS) can identify binding partners of adaptor proteins. For instance, LIS1 interactors were mapped using proteomics. Proximity labeling (BioID) can capture transient interactions in living cells.
Imaging and Live-Cell Assays
Fluorescence microscopy and live-cell imaging can visualize adaptor recruitment and complex assembly. For example, MAVS aggregation was observed using fluorescence microscopy. FRET biosensors can detect conformational changes upon adaptor binding.
Transcriptomic and Functional Assays
RNA-seq after CRISPR knockout of adaptor genes reveals downstream transcriptional changes. Functional assays such as inflammasome activation (IL-1β ELISA) or interferon reporter assays measure pathway output [6,7].
How CRISPR Can Be Used to Study GO:0060090 molecular adaptor activity
Knockout
CRISPR knockout of adaptor genes (e.g., STING1, MAVS, NEK7) abolishes their function, allowing researchers to assess their role in signaling pathways. For example, NEK7 knockout impairs NLRP3 inflammasome activation.
Point Mutation
Introducing disease-associated point mutations (e.g., in STING1) via CRISPR base editing or HDR can model autoinflammatory conditions and dissect domain-specific functions.
Knock-in
Tagged knock-in (e.g., GFP or HA) enables visualization and purification of adaptor proteins. Knock-in of reporter genes can monitor pathway activation in real time.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can elevate adaptor levels to study gain-of-function phenotypes, such as YAP/TAZ-driven fibrosis [3,5].
How EDITGENE Supports molecular adaptor activity Research
Researchers studying molecular adaptor activity-related genes often need to determine whether a candidate gene is causally involved in a specific pathway or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for molecular adaptor activity research.
Frequently Asked Questions About molecular adaptor activity
What is molecular adaptor activity?
Molecular adaptor activity (GO:0060090) is the binding activity of a molecule that brings together two or more molecules through selective, non-covalent interactions, enabling coordinated function.
What genes are involved in molecular adaptor activity?
Key genes include LIS1, STING1, MAVS, NEK7, YAP1, and WWTR1 (TAZ), among others [2,3,5,6,7,8].
How does molecular adaptor activity differ from enzyme activity?
Adaptor proteins lack catalytic activity; they physically bridge molecules, whereas enzymes catalyze chemical reactions.
What diseases are associated with defective molecular adaptor activity?
Fibrosis, autoinflammatory diseases, cancer, and neurodegeneration have been linked to adaptor dysfunction [2,3,4,5,6,7,8].
How can CRISPR be used to study molecular adaptor activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of adaptor genes to study their function [2,6,7].
What methods are used to identify adaptor protein interactions?
AP-MS, BioID, and yeast two-hybrid are commonly used to map adaptor interactomes [2,8].
What is the role of STING as a molecular adaptor?
STING bridges cytosolic DNA sensing to TBK1-mediated IRF3 phosphorylation, activating interferon responses.
How does MAVS function as a molecular adaptor?
MAVS forms prion-like aggregates that serve as signaling platforms for antiviral innate immunity.
What is the role of NEK7 in inflammasome activation?
NEK7 acts as an adaptor linking potassium efflux to NLRP3 inflammasome assembly and activation.
How does YAP/TAZ adaptor activity contribute to fibrosis?
YAP/TAZ mediate mechanosignaling and cooperate with TGF-β/SMAD to drive fibroblast activation and fibrosis [3,5].
Conclusion
Molecular adaptor activity (GO:0060090) is a cornerstone of cellular signaling, enabling the assembly of multiprotein complexes that drive diverse biological processes. From dynein-dynactin assembly by LIS1 to innate immune signaling via STING and MAVS [7,8], adaptor proteins are essential for coordinating cellular responses. Their dysregulation is implicated in fibrosis, inflammation, cancer, and neurodegeneration, making them attractive therapeutic targets. CRISPR-based models and advanced screening technologies are invaluable for dissecting adaptor function and identifying new drug targets. EDITGENE offers a full suite of services to support research on molecular adaptor activity, from knockout cell lines to bioinformatics analysis.
References
- 1. Kirk B et al.. 2020. Muscle, Bone, and Fat Crosstalk: the Biological Role of Myokines, Osteokines, and Adipokines.. Curr Osteoporos Rep 18(4):388-400 PMID: 32529456
- 2. Singh K et al.. 2024. Molecular mechanism of dynein-dynactin complex assembly by LIS1.. Science 383(6690):eadk8544 PMID: 38547289
- 3. Liu F et al.. 2015. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.. Am J Physiol Lung Cell Mol Physiol 308(4):L344-57 PMID: 25502501
- 4. Zhong Z et al.. 2016. NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria.. Cell 164(5):896-910 PMID: 26919428
- 5. Gallardo FS et al.. 2025. Role of TGF-β/SMAD/YAP/TAZ signaling in skeletal muscle fibrosis.. Am J Physiol Cell Physiol 328(3):C1015-C1028 PMID: 39925133
- 6. He Y et al.. 2016. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.. Nature 530(7590):354-7 PMID: 26814970
- 7. Tanaka Y et al.. 2012. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway.. Sci Signal 5(214):ra20 PMID: 22394562
- 8. Hou F et al.. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response.. Cell 146(3):448-61 PMID: 21782231
